Tevimbra

Active Ingredient(s): Tislelizumab-jsgr
FDA Approved: * March 13, 2024
Pharm Company: * BEIGENE
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tevimbra 10 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 72579-121
Labeler:
Beigene USA, Inc.